🚀 Today's Biggest Winners – Who's Crushing It? | January 13, 2026
BEAM, MTSI, BILI made moves today. Here's what you need to know.
Top Picks
Disclaimer: This AI-generated analysis is for educational and informational purposes only. It does not constitute financial advice. Always do your own research and consult with a licensed financial advisor before making investment decisions.
Market Overview
Key Observation
The Day Gainers screener shows broad upside with a median % change of 9.34% and multiple large single-day movers (max change 22.29%), driven by several names near 52-week highs. Many gainers show elevated volume relative to their 3-month average, indicating conviction behind moves.
Volume Analysis
Median volume spike is 1.5x, with several stocks showing outsized spikes (MTSI 3.78x, KC 3.74x, BILI 3.60x, BEAM 3.45x), suggesting concentrated buying interest in a subset of names while some other gainers show only modest volume increases.
Top PicksShowing 2 of 5
BEAM
Analysis
The data suggests BEAM is a high-conviction momentum name: +22.29% intraday with a 3.45x volume ratio, high momentum score (75), uptrend and trading near the upper third of its 52-week range (88.0). Analyst sentiment is 'Strong Buy', and market cap ($3.42B) places it in mid-cap biotech momentum cohort.
Key Metrics
Change +22.29%; Volume ratio 3.45x; Momentum score 75
Risk Factors
Unprofitable valuation and biotech sector volatility; elevated PB (3.4) versus peers.
Suggested Action
The data suggests watching for a confirmed close above recent intraday highs with continued volume >2x; if using a trade, define risk limits (e.g., pre-defined stop or size) and monitor for rapid reversal given biotech volatility.
MTSI
Analysis
MTSI shows strong breakout characteristics: trading at 98.3% of its 52-week range, intraday +12.97% with the largest volume spike in the sample (3.78x), and an uptrend noted in the data. Momentum score 55 and 'Strong Buy' analyst view support momentum interpretation.
Key Metrics
Range position 98.3%; Volume ratio 3.78x; Change +12.97%
Risk Factors
Valuation metrics absent for earnings profitability (listed as unprofitable) and high PB (11.1) suggest elevated valuation risk.
Suggested Action
The data suggests monitoring for continuation above the 52-week range high with sustained volume; consider waiting for a pullback to volume-supported levels or use tight risk management if trading the breakout.
+3 more top picks available
Sign up free to unlock all picks
Unlock Full Analysis
Sign up for free to access the complete Gainers Cockpit analysis
You're missing out on:
By signing up, you agree to our Terms of Service and Privacy Policy